| Date | Form | Description | Docs | XBRL | Pages |
| 02/14/11 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
102 | |
| 01/31/11 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
4 | |
| 06/29/10 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
81 | |
| 03/10/10 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
80 | |
| 01/29/10 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
121 | |
| 01/16/09 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
59 | |
| 01/15/09 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 01/15/08 | 10-K | Annual report pursuant to section 13 and 15(d) |
|
57 | |
| 01/15/08 | NT 10-K | Notice under Rule 12b25 of inability to timely file all or part of a Form 10-K, 10-KSB, or 10KT |
|
3 | |
| 01/25/07 | 10-K/A | Annual report pursuant to section 13 and 15(d) |
|
10 |
Latest News & Events
Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention
Read More...Anixa Biosciences CEO Provides Letter to Shareholders
Read More...Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10
Read More...